Wolverine Trading, LLC Sage Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.02 - $13.08 $134,082 - $249,828	19,100 New	19,100 $137,000
Q3 2023 Nov 15, 2023	BUY	$16.75 - $48.98 $10,050 - $29,387	600 Added 4.58%	13,700 $281,000
Q2 2023 Aug 23, 2023	SELL	$40.65 - $59.54 $12,195 - $17,862	-300 Reduced 2.24%	13,100 $615,000
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $144,900 - $196,245	-4,500 Reduced 25.14%	13,400 $511,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $112,980 - $151,445	3,500 Added 24.31%	17,900 $709,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $24,768 - $34,191	900 Added 6.67%	14,400 $472,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $153,550 - $228,550	5,000 Added 58.82%	13,500 $463,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $3,706 - $4,711	-100 Reduced 1.16%	8,500 $368,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $152,988 - $218,006	-3,800 Reduced 30.65%	8,600 $380,000
Q2 2021 Aug 06, 2021	BUY	$54.88 - $79.29 $296,352 - $428,166	5,400 Added 77.14%	12,400 $699,000
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $1.29 Million - $1.76 Million	-18,200 Reduced 72.22%	7,000 $513,000
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $105,138 - $160,308	-1,800 Reduced 6.67%	25,200 $2.23 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $4,113 - $6,245	-100 Reduced 0.37%	27,000 $1.61 Million
Q2 2020 Aug 13, 2020	SELL	$25.95 - $43.15 $267,285 - $444,445	-10,300 Reduced 27.54%	27,100 $1.13 Million
Q1 2020 May 11, 2020	BUY	$26.15 - $77.24 $978,010 - $2.89 Million	37,400 New	37,400 $1.1 Million
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $1.94 Million - $3.55 Million	-21,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $516,222 - $880,173	6,300 Added 40.91%	21,700 $1.93 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $2.13 Million - $2.6 Million	15,400 New	15,400 $2.18 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $8.28 Million - $10.5 Million	-54,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $935,088 - $2.58 Million	15,400 Added 39.49%	54,400 $8.96 Million
Q3 2017 Nov 15, 2017	BUY	$61.4 - $88.52 $2.39 Million - $3.45 Million	39,000	39,000 $2.43 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account